Filed Pursuant to 424(b)(5)
Registration No. 333-221127
The information in this preliminary prospectus supplement is not complete and may be changed. We will amend and complete the information in this preliminary prospectus supplement. This preliminary prospectus supplement and the prospectus are not offers to sell nor solicitations of offers to buy these securities in any jurisdiction where such offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED NOVEMBER 7, 2019
PRELIMINARY PROSPECTUS SUPPLEMENT
(To Prospectus Dated October 25, 2017)
![LOGO](https://capedge.com/proxy/424B5/0001193125-19-286559/g732457g94q36.jpg)
6,750,000 Equity Units
(Initially Consisting of 6,750,000 Corporate Units)
Stanley Black & Decker, Inc.
Stanley Black & Decker, Inc. is offering 6,750,000 Equity Units. Each Equity Unit will have a stated amount of $100 and will initially be a “Corporate Unit” consisting of a purchase contract issued by us and, initially, a 1/10, or 10%, undivided beneficial ownership in one share of 0% Series D Cumulative Perpetual Convertible Preferred Stock, without par value, with a liquidation preference of $1,000 per share, issued by us, which we refer to as the “convertible preferred stock.”
| • | | The purchase contract will obligate you to purchase from us, on November 15, 2022, for a price of $100, a number of newly-issued shares of our common stock equal to the applicable settlement rate, which will not exceed shares (subject to anti-dilution adjustments), as described in this prospectus supplement. We will pay you quarterly contract adjustment payments at the rate of % per year on the stated amount of $100 per Equity Unit, subject to our right to defer such contract adjustment payments as described in this prospectus supplement. |
| • | | The convertible preferred stock will initially not bear any dividends and the liquidation preference of the convertible preferred stock will not accrete. The convertible preferred stock will be remarketed as described in this prospectus supplement. In connection with any successful remarketing, we may (but are not required to) modify certain terms of all outstanding shares of convertible preferred stock (whether or not remarketed), including the dividend rate, conversion rate, the redemption date and/or the fundamental change conversion right. After any successful remarketing in connection with which the dividend rate on the convertible preferred stock is increased, we will pay cumulative dividends on the convertible preferred stock, when, as, and if declared by our board of directors, quarterly in arrears, from the applicable remarketing settlement date. |
| • | | Any contract adjustment payments on the purchase contracts or any dividends on the convertible preferred stock (which will only accrue after a successful remarketing in connection with which the dividend rate on the convertible preferred stock is increased) will be paid in cash, shares of our common stock, or a combination thereof, at our election, subject to certain limitations as described in this prospectus supplement, unless we have previously irrevocably elected a contract adjustment payment method or dividend payment method to apply. |
| • | | We may not redeem any shares of the convertible preferred stock prior to December 22, 2022. We may redeem for cash all or any portion of the outstanding shares of convertible preferred stock, at our option, on or after December 22, 2022 at a redemption price equal to 100% of the liquidation preference per share of convertible preferred stock to be redeemed, plus any accumulated and unpaid dividends, if any (whether or not declared) (which will only accrue from and after the settlement date for a successful remarketing in connection with which the dividend rate on the convertible preferred stock is increased) to, but excluding, the redemption date. |
| • | | Holders of separate shares of convertible preferred stock that are not a part of Corporate Units may convert their shares at their option prior to November 15, 2022 only upon the occurrence of a fundamental change if such fundamental change occurs prior to a successful remarketing. On and after November 15, 2022, holders of shares of convertible preferred stock may convert some or all of their shares at their option at any time, all as described in this prospectus supplement. |
| • | | The conversion rate will initially be shares of our common stock per share of convertible preferred stock, equivalent to a conversion price of approximately $ per share of common stock. The conversion rate will be subject to adjustment as described herein. |
| • | | Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, as described in this prospectus supplement, unless we have previously irrevocably elected a settlement method to apply. |
| • | | You can create Treasury Units from Corporate Units by substituting Treasury securities for your convertible preferred stock comprising a part of the Corporate Units, and you can recreate Corporate Units by substituting your convertible preferred stock for the Treasury securities comprising a part of the Treasury Units, in each case, subject to certain conditions described in this prospectus supplement. |
| • | | Your convertible preferred stock (or after a successful optional remarketing, the applicable ownership interest in a Treasury portfolio), Treasury securities or, in certain circumstances described herein, cash, as the case may be, that are components of Equity Units will be pledged to us to secure your obligation under the related purchase contract. |
| • | | If there is a successful optional remarketing of the convertible preferred stock as described in this prospectus supplement, and you hold Corporate Units, a portion of your applicable ownership interest in the Treasury portfolio purchased with the proceeds from the remarketing will be used to satisfy your payment obligations under the purchase contract. If there is a successful final remarketing, as described in this prospectus supplement, and you hold Corporate Units, the proceeds from the remarketing will be used to satisfy your payment obligations under the purchase contract. |
We intend to use the net proceeds from this offering, together with cash on hand, to redeem in full our existing 5.75% Junior Subordinated Debentures due 2052 (our “2052 Debentures”). This prospectus supplement does not constitute a notice of redemption of our 2052 Debentures. We also expect to use approximately $ of the net proceeds from this offering, together with cash on hand, to enter into the capped call transactions described in this prospectus supplement. See “Use of Proceeds.”
Our common stock is listed and traded on the New York Stock Exchange under the symbol “SWK.” The reported last sale price of our common stock on the New York Stock Exchange on November 6, 2019 was $159.24 per share. We intend to apply for listing of the Corporate Units on the New York Stock Exchange under the symbol “SWT.” Prior to this offering, there has been no public market for the Corporate Units.
Investing in our Equity Units involves risks. See “Risk Factors” beginning on pageS-26.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the related prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Corporate Unit | | | Total | |
Initial public offering price | | $ | 100 | | | $ | 675,000,000 | |
Underwriting discount | | $ | | | | $ | | |
Proceeds, before expenses, to Stanley Black & Decker, Inc. | | $ | | | | $ | | |
The public offering price set forth above does not include accumulated contract adjustment payments, if any. Contract adjustment payments on the purchase contracts will accrue for purchasers in this offering from November , 2019.
The underwriters may purchase up to an additional 750,000 Corporate Units at the public offering price less the underwriting discount within a12-day period beginning on the issue date of the Equity Units in order to cover over-allotments, if any.
The underwriters expect to deliver the Corporate Units in book-entry form only through the facilities of The Depository Trust Company against payment in New York, New York on or about November , 2019.
Joint Book-Running Managers
| | | | |
Citigroup | | Credit Suisse | | Wells Fargo Securities |
Structuring Agent | | Structuring Agent | | |
November , 2019